<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Mecasermin</title><link>https://peptidescanner.com/peptides/mecasermin/</link><description>Versioned, source-linked PeptideScanner evidence objects for Mecasermin. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/mecasermin.xml" rel="self" type="application/rss+xml"/><item><title>Drugs@FDA application BLA021839</title><link>https://peptidescanner.com/stories/fda-drugs-bla021839/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-bla021839:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#fda-drugs-bla021839-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2005-08-30. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 97-10541</title><link>https://peptidescanner.com/stories/federal-register-97-10541/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-97-10541:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#federal-register-97-10541-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 1997-04-23. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 98-7053</title><link>https://peptidescanner.com/stories/federal-register-98-7053/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-98-7053:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#federal-register-98-7053-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 1998-03-19. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice E6-12571</title><link>https://peptidescanner.com/stories/federal-register-e6-12571/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-e6-12571:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#federal-register-e6-12571-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2006-08-03. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice E6-9138</title><link>https://peptidescanner.com/stories/federal-register-e6-9138/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-e6-9138:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#federal-register-e6-9138-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2006-06-13. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-17</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00516386</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00516386-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00516386-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct00516386-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-11-18. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00571727</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00571727-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00571727-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct00571727-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-07-06. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00903110</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00903110-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00903110-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct00903110-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-02-06. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01406444</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01406444-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01406444-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01406444-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2020-07-17. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01438086</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01438086-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01438086-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01438086-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-03-30. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01446783</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01446783-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01446783-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01446783-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2012-11-20. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01588093</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01588093-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01588093-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01588093-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2012-04-30. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01777542</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01777542-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01777542-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct01777542-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-03-26. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02636270</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02636270-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02636270-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#clinicaltrials-gov-nct02636270-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-02-28. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-16</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>USAN Council. List No. 419. New names. Mecasermin.</title><link>https://peptidescanner.com/stories/pubmed-pmid-10576957-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-10576957-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-10576957-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2007-11-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.</title><link>https://peptidescanner.com/stories/pubmed-pmid-15777106-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-15777106-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-15777106-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-10-25. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Mecasermin Tercica.</title><link>https://peptidescanner.com/stories/pubmed-pmid-16625824-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-16625824-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-16625824-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2007-11-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Mecasermin rinfabate.</title><link>https://peptidescanner.com/stories/pubmed-pmid-17380212-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-17380212-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-17380212-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2017-04-27. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Mecasermin rinfabate: rhIGF-I/rhIGFBP-3 complex: iPLEX.</title><link>https://peptidescanner.com/stories/pubmed-pmid-18363546-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-18363546-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-18363546-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-11-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Mecasermin.</title><link>https://peptidescanner.com/stories/pubmed-pmid-18481900-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-18481900-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-18481900-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-31. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Mecasermin (recombinant human insulin-like growth factor I).</title><link>https://peptidescanner.com/stories/pubmed-pmid-19198769-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-19198769-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-19198769-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2012-11-15. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Allergic reaction to mecasermin.</title><link>https://peptidescanner.com/stories/pubmed-pmid-19663134-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-19663134-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-19663134-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2009-08-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency.</title><link>https://peptidescanner.com/stories/pubmed-pmid-19707272-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-19707272-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-19707272-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Postprandial hyperglycemia corrected by IGF-I (Increlex®) in Laron syndrome.</title><link>https://peptidescanner.com/stories/pubmed-pmid-22986916-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-22986916-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-22986916-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2016-05-19. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Desensitization to mecasermin in an insulin-like growth factor 1-deficient patient.</title><link>https://peptidescanner.com/stories/pubmed-pmid-25843163-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-25843163-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-25843163-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2015-05-29. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Recombinant production of mecasermin in E. coli expression system.</title><link>https://peptidescanner.com/stories/pubmed-pmid-26339260-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-26339260-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-26339260-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2020-09-30. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Mecasermin in Insulin Receptor-Related Severe Insulin Resistance Syndromes: Case Report and Review of the Literature.</title><link>https://peptidescanner.com/stories/pubmed-pmid-29695048-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29695048-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-29695048-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-01-24. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Cardiac examination in children with Laron syndrome undergoing mecasermin therapy.</title><link>https://peptidescanner.com/stories/pubmed-pmid-29750649-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29750649-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-29750649-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-02-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Efficient process development for high-level production, purification, formulation, and characterization of recombinant mecasermin in Escherichia coli.</title><link>https://peptidescanner.com/stories/pubmed-pmid-32692415-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-32692415-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-32692415-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-09-29. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Alterations in Stem Cell Populations in IGF-1 Deficient Pediatric Patients Subjected to Mecasermin (Increlex) Treatment.</title><link>https://peptidescanner.com/stories/pubmed-pmid-36269524-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-36269524-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-36269524-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-27. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Mecasermin for primary insulin-like growth factor-1 deficiency.</title><link>https://peptidescanner.com/stories/pubmed-pmid-36479333-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-36479333-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-36479333-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-12-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Mecasermin for the treatment of Rett Syndrome: a systematic review.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41174329-mecasermin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41174329-mecasermin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/mecasermin.json#pubmed-pmid-41174329-mecasermin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-11-05. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-16</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
